Pharma News

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus erythe...

With deal, drug wholesaler grows its biopharma services platform.

The European Commission has approved Roche’s Vabysmo (faricimab) for the treatment of neovascular or ‘wet’ age-related macular degeneration and visual impairment due to diabetic macular edema...

Proteomic analysis suggests zika virus causes alterations in the expression of proteins linked to the metabolism of developing neural cells, and proteins associated with the maturation of oligodend...

Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of mu...

Increases in depression without commensurate increases in treatment are widespread, reports a study conducted at Columbia University Mailman School of Public Health and City University of...

The Centers for Disease Control and Prevention (CDC) has provided guidelines on using Siga Technologies’ Tpoxx (tecovirimat) in treating monkeypox.

Pfizer’s close-fought contest with GSK to bring a next-generation meningitis vaccine to market has entered the final rounds, with the former ahead on points following the readout of a pivotal pha...

Prospects for AstraZeneca’s oral Factor D inhibitor danicopan were looking poor after it failed a phase 2 trial in a rare kidney disease in 2020, but a new readout could reinvigorate the drug. ...

Jasper Therapeutics’ investigational monoclonal antibody JSP191 has gained Fast Track status from the FDA for the treatment of patients with severe combined immunodeficiency (SCID) undergoing all...

The Lancet Commission published a long critical of the World Health Organizationof the response to the COVID-19 pandemic. The WHO, in turn, welcomed the Commission’s recommendations, but offered...

Therapy shows positive clinical efficacy and favorable tolerability as a monotherapy and in combination with cetuximab in heavily pretreated patients who have a KRASG12C mutation. ...